Literature DB >> 30788502

Evidence of Recent Genomic Evolution in Gonococcal Strains With Decreased Susceptibility to Cephalosporins or Azithromycin in the United States, 2014-2016.

Jesse C Thomas1, Sandra Seby1, A Jeanine Abrams1, Jack Cartee1, Sean Lucking1, Eshaw Vidyaprakash1, Matthew Schmerer1, Cau D Pham1, Jaeyoung Hong1, Elizabeth Torrone1, Sancta St Cyr1, William M Shafer2,3,4, Kyle Bernstein1, Ellen N Kersh1, Kim M Gernert1.   

Abstract

BACKGROUND: Given the lack of new antimicrobials or a vaccine, understanding the evolutionary dynamics of Neisseria gonorrhoeae is a significant public and global health priority. We investigated the emergence and spread of gonococcal strains with decreased susceptibility to cephalosporins and azithromycin using detailed genomic analyses of gonococcal isolates collected in the United States, 2014-2016.
METHODS: We sequenced genomes of 649 isolates collected through the Gonococcal Isolate Surveillance Project. We examined the genetic relatedness of isolates and assessed associations between clades and various genotypic and phenotypic combinations.
RESULTS: We identified a large and clonal lineage of strains (MLST ST9363) associated with elevated azithromycin minimum inhibitory concentration (AZIem), characterized by a mosaic mtr locus (C substitution in the mtrR promoter, mosaic mtrR and mtrD). Mutations in 23S rRNA were sporadically distributed among AZIem strains. Another clonal group (MLST ST1901) possessed 7 unique PBP2 patterns, and it shared common mutations in other genes associated with cephalosporin resistance.
CONCLUSIONS: Whole-genome sequencing methods can enhance monitoring of antimicrobial resistant gonococcal strains by identifying gonococcal populations containing mutations of concern. These methods could inform the development of point-of-care diagnostic tests designed to determine the specific antibiotic susceptibility profile of a gonococcal infection in a patient.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  zzm321990 Neisseria gonorrhoeaezzm321990 ; antibiotic resistance; cephalosporins; genomic epidemiology; gonorrhea; macrolide

Mesh:

Substances:

Year:  2019        PMID: 30788502      PMCID: PMC6581898          DOI: 10.1093/infdis/jiz079

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  43 in total

1.  Occurrence of high-level azithromycin-resistant Neisseria gonorrhoeae isolates in China.

Authors:  Juan Xue; Chunshan Ni; Haiyong Zhou; Chuanling Zhang; Stijn van der Veen
Journal:  J Antimicrob Chemother       Date:  2015-08-27       Impact factor: 5.790

2.  Alanine 501 Mutations in Penicillin-Binding Protein 2 from Neisseria gonorrhoeae: Structure, Mechanism, and Effects on Cephalosporin Resistance and Biological Fitness.

Authors:  Joshua Tomberg; Alena Fedarovich; Leah R Vincent; Ann E Jerse; Magnus Unemo; Christopher Davies; Robert A Nicholas
Journal:  Biochemistry       Date:  2017-02-16       Impact factor: 3.162

3.  A Case of Decreased Susceptibility to Ceftriaxone in Neisseria gonorrhoeae in the Absence of a Mosaic Penicillin-Binding Protein 2 (penA) Allele.

Authors:  A Jeanine Abrams; Robert D Kirkcaldy; Kevin Pettus; Jan L Fox; Grace Kubin; David L Trees
Journal:  Sex Transm Dis       Date:  2017-08       Impact factor: 2.830

4.  Mixed gonococcal infections in a high-risk population, Sydney, Australia 2015: implications for antimicrobial resistance surveillance?

Authors:  Namraj Goire; Ratan Kundu; Ella Trembizki; Cameron Buckley; Tiffany R Hogan; David A Lewis; James M Branley; David M Whiley; Monica M Lahra
Journal:  J Antimicrob Chemother       Date:  2016-10-05       Impact factor: 5.790

5.  Estimating the prevalence of mixed-type gonococcal infections in Queensland, Australia.

Authors:  Ella Trembizki; Christine Doyle; Cameron Buckley; Amy Jennison; Helen Smith; John Bates; Theo Sloots; Michael Nissen; Monica M Lahra; David Whiley
Journal:  Sex Health       Date:  2015-10       Impact factor: 2.706

6.  Novel penA mutations identified in Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone isolated between 2000 and 2014 in Japan.

Authors:  Kensaku Seike; Mitsuru Yasuda; Kyoko Hatazaki; Kosuke Mizutani; Kazuya Yuhara; Yasuhisa Ito; Yoshinori Fujimoto; Shin Ito; Tomohiro Tsuchiya; Shigeaki Yokoi; Masahiro Nakano; Takashi Deguchi
Journal:  J Antimicrob Chemother       Date:  2016-05-13       Impact factor: 5.790

7.  Impact of fluoroquinolone resistance mutations on gonococcal fitness and in vivo selection for compensatory mutations.

Authors:  Anjali N Kunz; Afrin A Begum; Hong Wu; Jonathan A D'Ambrozio; James M Robinson; William M Shafer; Margaret C Bash; Ann E Jerse
Journal:  J Infect Dis       Date:  2012-04-05       Impact factor: 5.226

8.  New Ceftriaxone- and Multidrug-Resistant Neisseria gonorrhoeae Strain with a Novel Mosaic penA Gene Isolated in Japan.

Authors:  Shu-Ichi Nakayama; Ken Shimuta; Kei-Ichi Furubayashi; Takuya Kawahata; Magnus Unemo; Makoto Ohnishi
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

9.  A novel mechanism of high-level, broad-spectrum antibiotic resistance caused by a single base pair change in Neisseria gonorrhoeae.

Authors:  Elizabeth A Ohneck; Yaramah M Zalucki; Paul J T Johnson; Vijaya Dhulipala; Daniel Golparian; Magnus Unemo; Ann E Jerse; William M Shafer
Journal:  mBio       Date:  2011-09-20       Impact factor: 7.867

10.  Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study.

Authors:  Yonatan H Grad; Robert D Kirkcaldy; David Trees; Janina Dordel; Simon R Harris; Edward Goldstein; Hillard Weinstock; Julian Parkhill; William P Hanage; Stephen Bentley; Marc Lipsitch
Journal:  Lancet Infect Dis       Date:  2014-01-22       Impact factor: 25.071

View more
  15 in total

1.  Genomic Characterization of Neisseria gonorrhoeae Strains from 2016 U.S. Sentinel Surveillance Displaying Reduced Susceptibility to Azithromycin.

Authors:  Matthew W Schmerer; A Jeanine Abrams; Sandra Seby; Jesse C Thomas; John Cartee; Sean Lucking; Eshaw Vidyaprakash; Cau D Pham; Samera Sharpe; Kevin Pettus; Sancta B St Cyr; Elizabeth A Torrone; Ellen N Kersh; Kim M Gernert
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

Review 2.  Expanding U.S. Laboratory Capacity for Neisseria gonorrhoeae Antimicrobial Susceptibility Testing and Whole-Genome Sequencing through the CDC's Antibiotic Resistance Laboratory Network.

Authors:  Ellen N Kersh; Cau D Pham; John R Papp; Robert Myers; Richard Steece; Grace Kubin; Romesh Gautom; Evelyn E Nash; Samera Sharpe; Kim M Gernert; Matthew Schmerer; Brian H Raphael; Tara Henning; Anne M Gaynor; Olusegun Soge; Karen Schlanger; Robert D Kirkcaldy; Sancta B St Cyr; Elizabeth A Torrone; Kyle Bernstein; Hillard Weinstock
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

3.  Six penA Codons Accurately and Reliably Predict Cefixime-Decreased Susceptibility in Neisseria gonorrhoeae.

Authors:  Xiaomeng Deng; Jeffrey D Klausner
Journal:  J Infect Dis       Date:  2020-02-18       Impact factor: 5.226

4.  Reply: Evidence of Recent Genomic Evolution in Gonococcal Strains With Decreased Susceptibility to Cephalosporins or Azithromycin in the United States, 2014-2016.

Authors:  Jesse C Thomas; Ellen N Kersh; Kim M Gernert; William M Shafer; Brian H Raphael
Journal:  J Infect Dis       Date:  2020-02-18       Impact factor: 5.226

5.  Global Emergence and Dissemination of Neisseria gonorrhoeae ST-9363 Isolates with Reduced Susceptibility to Azithromycin.

Authors:  Sandeep J Joseph; Jesse C Thomas; Matthew W Schmerer; John C Cartee; Sancta St Cyr; Karen Schlanger; Ellen N Kersh; Brian H Raphael; Kim M Gernert
Journal:  Genome Biol Evol       Date:  2022-01-04       Impact factor: 3.416

6.  Demographic and Epidemiological Characteristics Associated With Reduced Antimicrobial Susceptibility to Neisseria gonorrhoeae in the United States, Strengthening the US Response to Resistant Gonorrhea, 2018 to 2019.

Authors:  Karen E Gieseker; Emily R Learner; Kerry Mauk; Lindley A Barbee; Candice J McNeil; Gerald L Hasty; Jamie M Black; Kimberly Johnson; Trang Quyen Nguyen; Dhana Shrestha; Cau D Pham; Sancta St Cyr; Karen Schlanger; Robert D Kirkcaldy
Journal:  Sex Transm Dis       Date:  2021-12-01       Impact factor: 3.868

7.  Azithromycin susceptibility of Neisseria gonorrhoeae in the USA in 2017: a genomic analysis of surveillance data.

Authors:  Kim M Gernert; Sandra Seby; Matthew W Schmerer; Jesse C Thomas; Cau D Pham; Sancta St Cyr; Karen Schlanger; Hillard Weinstock; William M Shafer; Brian H Raphael; Ellen N Kersh
Journal:  Lancet Microbe       Date:  2020-08

8.  Evidence of Horizontal Gene Transfer of 50S Ribosomal Genes rplB, rplD, and rplY in Neisseria gonorrhoeae.

Authors:  Sheeba Santhini Manoharan-Basil; Jolein Gyonne Elise Laumen; Christophe Van Dijck; Tessa De Block; Irith De Baetselier; Chris Kenyon
Journal:  Front Microbiol       Date:  2021-06-10       Impact factor: 5.640

Review 9.  Bioinformatics tools used for whole-genome sequencing analysis of Neisseria gonorrhoeae: a literature review.

Authors:  Reema Singh; Anthony Kusalik; Jo-Anne R Dillon
Journal:  Brief Funct Genomics       Date:  2022-04-11       Impact factor: 4.840

10.  Genomic epidemiology and population structure of Neisseria gonorrhoeae in Norway, 2016-2017.

Authors:  Kristian Alfsnes; Vegard Eldholm; Anne Olaug Olsen; Ola Brønstad Brynildsrud; Jon Bohlin; Martin Steinbakk; Dominique A Caugant
Journal:  Microb Genom       Date:  2020-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.